Clinicians must recognize the broad and atypical clinical spectrum of ATTRwt to correctly identify patients for emerging disease-modifying treatments.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
González-López et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: